Resultats globals: 15 registres trobats en 0.02 segons.
Articles, 12 registres trobats
Llibres i col·leccions, 1 registres trobats
Documents de recerca, 1 registres trobats
Materials acadèmics, 1 registres trobats
Articles 12 registres trobats  1 - 10següent  anar al registre:
1.
7 p, 1.3 MB Use of an acellular collagen-elastin matrix to support bladder regeneration in a porcine model of peritoneocystoplasty / Gasanz, Carlos (Hospital Universitari Vall d'Hebron) ; Raventós, Carles (Universitat Autònoma de Barcelona. Departament de Cirurgia) ; Temprana-Salvador, Jordi (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Esteves, Marielle (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Fonseca, Carla (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; de Torres, Inés (Universitat Autònoma de Barcelona. Departament de Ciències Morfològiques) ; Morote Robles, Juan (Universitat Autònoma de Barcelona. Departament de Cirurgia) ; Hospital Universitari Vall d'Hebron
Bladder reconstruction without using the intestine remains a challenge to this day despite the development of new biomaterials and cell cultures. Human bladder engineering is merely anecdotic, and mostly in vitro and animal studies have been conducted. [...]
2018 - 10.5173/ceju.2018.1735
Central European Journal of Urology, Vol. 71 (august 2018) , p. 353-359  
2.
10 p, 964.3 KB Guideline on the use of onabotulinumtoxinA in chronic migraine : a consensus statement from the European Headache Federation / Bendtsen, Lars (University of Copenhagen) ; Sacco, Simona (University of L'Aquila. Neuroscience Section, Department of Applied Clinical Sciences and Biotechnology) ; Ashina, Messoud (University of Copenhagen) ; Mitsikostas, Dimos (National and Kapodistrian University of Athens. 1st Department of Neurology, Aeginition Hospital) ; Ahmed, Fayyaz (Hull York Medical School. Department of Neurosciences) ; Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Martelletti, Paolo (Sapienza University. Department of Clinical and Molecular Medicine) ; Universitat Autònoma de Barcelona ; Hospital Universitari Vall d'Hebron
OnabotulinumtoxinA is being increasingly used in the management of chronic migraine (CM). Treatment with onabotulinumtoxinA poses challenges compared with traditional therapy with orally administered preventatives. [...]
2018 - 10.1186/s10194-018-0921-8
Journal of headache and pain, Vol. 19 (september 2018)  
3.
8 p, 1.6 MB Outcome of Arthroscopic Treatment of Mucoid Degeneration of the Anterior Cruciate Ligament / Ventura, Diego (Universitat Autònoma de Barcelona. Departament de Cirurgia) ; Nuñez, Jorge H. (Hospital Universitari MútuaTerrassa (Terrassa, Catalunya)) ; Joshi Jubert, Nayana (Universitat Autònoma de Barcelona. Departament de Cirurgia) ; Castellet Feliu, Enric (Universitat Autònoma de Barcelona. Departament de Cirurgia) ; Minguell-Monyart, Joan (Universitat Autònoma de Barcelona. Departament de Cirurgia) ; Hospital Universitari Vall d'Hebron
Mucoid degeneration of the anterior cruciate ligament is a rare pathological entity. Several authors have identified this condition, described their experiences, and suggested their own guidelines for management. [...]
2018 - 10.4055/cios.2018.10.3.307
Clinics in Orthopedic Surgery, Vol. 10 (august 2018) , p. 307-314  
4.
4 p, 452.5 KB Adrenergic cardiomyopathy and cardiogenic shock as initial presentation of pheochromocytoma. A case report and review of the literature / Gil-Barrionuevo, Esther (Universitat Autònoma de Barcelona. Departament de Cirurgia) ; Balibrea Del Castillo, José María (Hospital Universitari Vall d'Hebron) ; Caubet, Enric (Universitat Autònoma de Barcelona. Departament de Cirurgia) ; González López, Óscar 1969- (Universitat Autònoma de Barcelona. Departament de Cirurgia) ; Vilallonga, Ramón (Universitat Autònoma de Barcelona. Departament de Cirurgia) ; Fort, José Manuel (Universitat Autònoma de Barcelona. Departament de Cirurgia) ; Ciudin, Andreea (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Armengol Carrasco, Manuel (Hospital Universitari Vall d'Hebron) ; Hospital Universitari Vall d'Hebron
Pheochromocytomas are infrequent tumors arised from the chromaphine cells of the adrenal sympathetic system. The excess of circulating catecholamines may lead to different cardiovascular disorders from silent alterations of the myocardial conduction to different forms of cardiomyopathy. [...]
2018 - 10.1016/j.ijscr.2018.06.024
International Journal of Surgery Case Reports, Vol. 49 (june 2018) , p. 145-148  
5.
10 p, 2.5 MB Population dynamics and antigenic drift of Bordetella pertussis following whole cell vaccine replacement, Barcelona, Spain, 1986-2015 / Mir-Cros, Alba (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Moreno-Mingorance, Albert (Hospital Universitari Vall d'Hebron) ; Martin-Gomez, M. Teresa (Departament de Genètica i de Microbiologia) ; Codina, María Gema (Hospital Universitari Vall d'Hebron) ; Cornejo-Sánchez, Thais (Hospital Universitari Vall d'Hebron) ; Rajadell Guiu, Mireia (Departament de Genètica i de Microbiologia) ; Van Esso, Diego (Institut Català de la Salut) ; Rodrigo Gonzalo de Líria, Carlos (Hospital Universitari Vall d'Hebron) ; Campins Martí, Magda (Hospital Universitari Vall d'Hebron) ; Jané i Checa, Mireia (Servei Català de la Salut) ; Pumarola Suñé, Tomàs (Hospital Universitari Vall d'Hebron) ; Fàbrega-Santamaria, Anna (Universitat de Vic - Universitat Central de Catalunya) ; González-López, Juanjo 1975- (Departament de Genètica i de Microbiologia) ; Hospital Universitari Vall d'Hebron
Among the factors associated with the resurgence of whooping cough, special emphasis has been given to pathogen adaptation after the introduction of the acellular vaccine (ACV). To assess the impact of the vaccine transition strategy from whole-cell vaccine (WCV) to ACV on population dynamics of Bordetella pertussis in Barcelona (Spain), we studied 339 isolates collected from 1986 to 2015 by PFGE and multi-locus variable-number tandem repeat analysis (MLVA). [...]
2019 - 10.1080/22221751.2019.1694395
Emerging microbes & infections, Vol. 8 (november 2019) , p. 1711-1720  
6.
16 p, 1.2 MB Incidence of direct oral anticoagulant use in patients with nonvalvular atrial fibrillation and characteristics of users in 6 European countries (2008-2015) : A cross-national drug utilization study / Ibáñez, Luisa (Universitat Autònoma de Barcelona) ; Sabaté, Mònica (Universitat Autònoma de Barcelona) ; Vidal Guitart, Xavier (Universitat Autònoma de Barcelona) ; Ballarín, Elena (Hospital Universitari Vall d'Hebron) ; Rottenkolber, Marietta (Klinikum der Universität München) ; Schmiedl, Sven (Helios University Hospital Wuppertal) ; Heeke, Andreas (AOK NORDWEST) ; Huerta, Consuelo (Agencia Española de Medicamentos y Productos Sanitarios) ; Martin Merino, Elisa (Agencia Española de Medicamentos y Productos Sanitarios) ; Montero, Dolores (Agencia Española de Medicamentos y Productos Sanitarios) ; Leon-Muñoz, Luz María (Agencia Española de Medicamentos y Productos Sanitarios) ; Gasse, Christiane (Aarhus University) ; Moore, Nicholas (INSERM CIC1401, Université de Bordeaux) ; Droz, Cécile (INSERM CIC1401, Université de Bordeaux) ; Lassalle, Régis (INSERM CIC1401, Université de Bordeaux) ; Aakjær, Mia (University of Copenhagen) ; Andersen, Morten (University of Copenhagen) ; De Bruin, Marie Louise (University of Copenhagen) ; Groenwold, Rolf (Leiden University Medical Center) ; van den Ham, Hendrika A. (Universiteit Utrecht, David de Wiedgebouw) ; Souverein, Patrick (Universiteit Utrecht, David de Wiedgebouw) ; Klungel, Olaf (University Medical Center Utrecht) ; Gardarsdottir, Helga (University of Iceland) ; Universitat Autònoma de Barcelona ; Hospital Universitari Vall d'Hebron
To estimate the incidence of direct oral anticoagulant drug (DOAC) use in patients with nonvalvular atrial fibrillation and to describe user and treatment characteristics in 8 European healthcare databases representing 6 European countries. [...]
2019 - 10.1111/bcp.14071
British Journal of Clinical Pharmacology, Vol. 85 (september 2019) , p. 2524-2539  
7.
4 p, 390.4 KB Sodium-glucose cotransporter inhibitors : beyond glycaemic control / Vergara, Ander (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Jacobs-Cachá, Conxita (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Soler, María José (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona ; Hospital Universitari Vall d'Hebron
Diabetes increases the risk of adverse cardiovascular and renal events. Recently, sodium-glucose co-transporter 2 (SGLT2) inhibitors have been demonstrated to reduce cardiovascular complications and slow diabetic kidney disease progression in patients with type 2 diabetes. [...]
2019 - 10.1093/ckj/sfz019
Clinical Kidney Journal, Vol. 12 (march 2019) , p. 322-325  
8.
5 p, 2.2 MB Sphenoid sinus mucocele : an unusual complication of head and neck irradiation in a North African woman / Brunet-Garcia, Aina (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Costa-Climent,, Mª Dolores (Consorci Hospitalari Provincial de Castelló) ; Pujol-Rodríguez, Maria (Hospital Universitari Vall d'Hebron) ; Brunet-Garcia, Laia (Hospital Sant Joan de Déu (Barcelona, Catalunya)) ; Faubel-Serra, Marta (Consorci Hospitalari Provincial de Castelló) ; Universitat Autònoma de Barcelona ; Universitat de València ; Hospital Universitari Vall d'Hebron
Mucocele is a common benign lesion otherwise rarely located in the sphenoid sinus. Some complications after head and neck irradiation have been described in the literature until now. To our knowledge, this is the first report of a sphenoid sinus mucocele in a North African patient treated some years before with radiotherapy for a nasopharyngeal carcinoma (NPC). [...]
2019 - 10.4317/jced.55161
Journal of Clinical and Experimental Dentistry, Vol. 11 (february 2019) , p. e208-e212  
9.
13 p, 6.2 MB Functional high-throughput screening reveals miR-323a-5p and miR-342-5p as new tumor-suppressive microRNA for neuroblastoma / Soriano, Aroa (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Masanas, Marc (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Boloix, Ariadna (Institut de Ciència de Materials de Barcelona) ; Masiá, Núria (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; París-Coderch, Laia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Piskareva, Olga (Royal College of Surgeons in Ireland and National Children's Research Centre Our Lady's Children's Hospital. Molecular and Cellular Therapeutics) ; Jiménez Jiménez, Carlos (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Henrich, Kai-Oliver (German Cancer Research Center (DKFZ). Neuroblastoma Genomics Group) ; Roma, Josep (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Westermann, Frank (German Cancer Research Center (DKFZ). Neuroblastoma Genomics Group) ; Stallings, Raymond L. (Royal College of Surgeons in Ireland and National Children's Research Centre Our Lady's Children's Hospital. Molecular and Cellular Therapeutics) ; Sábado, Constantino (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; de Toledo, Josep Sánchez (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Santamaría, Anna (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Gallego, Soledad (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Segura, Miguel F. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona ; Hospital Universitari Vall d'Hebron
The online version of this article (10. 1007/s00018-019-03041-4) contains supplementary material, which is available to authorized users.
Current therapies for most non-infectious diseases are directed at or affect functionality of the human translated genome, barely 2% of all genetic information. By contrast, the therapeutic potential of targeting the transcriptome, ~ 70% of the genome, remains largely unexplored. [...]

2019 - 10.1007/s00018-019-03041-4
Cellular and Molecular Life Sciences, Vol. 76 (february 2019) , p. 2231-2243  
10.
12 p, 1.5 MB MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice / Sastre-Garriga, Jaume (Centre d'Esclerosi Mútiple de Catalunya (Cemcat)) ; Pareto, Deborah (Hospital Universitari Vall d'Hebron) ; Battaglini, Marco (University of Siena. Department of Medicine, Surgery and Neuroscience) ; Rocca, Maria A. (IRCCS San Raffaele Scientific Institute (Milà, Itàlia). Institute of Experimental Neurology) ; Ciccarelli, Olga (University College London Hospitals. National Institute for Health Research Biomedical Research Centre) ; Enzinger, Christian (Medical University of Graz. Department of Neurology and Division of Neuroradiology, Vascular and Interventional Radiology, Department of Radiology) ; Wuerfel, Jens (University of Basel. Medical Image Analysis Center (MIAC AG) and Department of Biomedical Engineering) ; Sormani, Maria P. (IRCCS, Ospedale Policlinico San Martino, Genoa) ; Barkhof, Frederik (University College London. Institutes of Neurology and Healthcare Engineering) ; Yousry, Tarek A. (University College London Hospitals National Hospital for Neurology and Neurosurgery, University College London Institute of Neurology. Lysholm Department of Neuroradiology) ; De Stefano, Nicola (University of Siena. Department of Medicine, Surgery and Neuroscience) ; Tintoré, Mar (Centre d'Esclerosi Mútiple de Catalunya (Cemcat)) ; Filippi, Massimo (Vita-Salute San Raffaele University) ; Gasperini, Claudio (San Camillo Forlanini Hospital) ; Kappos, Ludwig (University Hospital Basel (Basilea, Suïssa)) ; Río, Jordi (Universitat Autònoma de Barcelona) ; Frederiksen, Jette (University of Copenhagen) ; Palace, Jackie (University of Oxford. Nuffield Department of Clinical Neurosciences) ; Vrenken, Hugo (Amsterdam Neuroscience, MS Center Amsterdam, Department of Radiology and Nuclear Medicine, Amsterdam UMC) ; Montalban, Xavier (University of Toronto. Division of Neurology, St Michael's Hospital) ; Rovira, Alex (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona ; Hospital Universitari Vall d'Hebron ; Centre d'Esclerosi Mútiple de Catalunya (Cemcat)
Early evaluation of treatment response and prediction of disease evolution are key issues in the management of people with multiple sclerosis (MS). In the past 20 years, MRI has become the most useful paraclinical tool in both situations and is used clinically to assess the inflammatory component of the disease, particularly the presence and evolution of focal lesions - the pathological hallmark of MS. [...]
2020 - 10.1038/s41582-020-0314-x
Nature Reviews. Neurology, Vol. 16 (february 2020) , p. 171-182  

Articles : 12 registres trobats   1 - 10següent  anar al registre:
Llibres i col·leccions 1 registres trobats  
1.
50 p, 1022.3 KB Autoinforme d'acreditació Vall d'Hebron Institut de Recerca (VHIR) / Hospital Universitari Vall d'Hebron. Institut de Recerca
2017  

Documents de recerca 1 registres trobats  
1.
49 p, 1.2 MB Estudio prospectivo comparando la gastrectomía tubular laparoscópica y la gastrectomía robótica para el tratamiento de la obesidad mórbida / Domingo González, Marta ; Armengol Carrasco, Manuel, dir. (Universitat Autònoma de Barcelona. Departament de Cirurgia) ; Vilallonga Puy, Ramón, dir. ; Universitat Autònoma de Barcelona. Departament de Cirurgia ; Hospital Universitari Vall d'Hebron ; Universitat Autònoma de Barcelona. Facultat de Medicina
La cirurgia de l'obesitat suposa una eina dins de l'arsenal terapèutic dels pacients afectes d'obesitat mòrbida. La gastrectomia vertical s'ha popularitzat com a tècnica i les noves tecnologies com la laparoscòpia s'utilitzen de forma habitual. [...]
La cirugía de la obesidad supone una herramienta dentro del arsenal terapéutico de los pacientes afectos de obesidad mórbida. La gastrectomía vertical se ha popularizado como técnica y las nuevas tecnologías como la laparoscopia se utilizan de forma habitual. [...]

2011  

Materials acadèmics 1 registres trobats  
1.
149 p, 2.2 MB Máster Universitario en Investigación Biomédica Traslacional / Hospital Universitari Vall d'Hebron. Institut de Recerca ; Universitat Autònoma de Barcelona
El màster en Recerca Biomèdica Translacional és un programa de caràcter oficial pensat per formar investigadors/es d'excel·lència, amb la combinació necessària de coneixements i competències científiques i mèdiques, que contribueixin a l'èxit de la recerca biomèdica translacional del futur. [...]
Bellaterra 2014 (Màsters)
5 documents

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.